2D-QSAR and Molecular Docking Studies of 5-Nitrofuranyl Derivatives as Potential Galactofuranosyltransferase 2 Inhibitors for Antitubercular Therapy.

Afreen N, Sharma BK, Sharma S, Vanangamudi M

Open source

DOI
10.2174/0113816128517337261019151723
Published
2026 Oct 27
Container
Current pharmaceutical design
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0113816128517337261019151723,
  title = {2D-QSAR and Molecular Docking Studies of 5-Nitrofuranyl Derivatives as Potential Galactofuranosyltransferase 2 Inhibitors for Antitubercular Therapy.},
  author = {Afreen N and Sharma BK and Sharma S and Vanangamudi M},
  year = {2026},
  journal = {Current pharmaceutical design},
  doi = {10.2174/0113816128517337261019151723},
  url = {https://doi.org/10.2174/0113816128517337261019151723}
}

RIS

TY  - JOUR
TI  - 2D-QSAR and Molecular Docking Studies of 5-Nitrofuranyl Derivatives as Potential Galactofuranosyltransferase 2 Inhibitors for Antitubercular Therapy.
AU  - Afreen N
AU  - Sharma BK
AU  - Sharma S
AU  - Vanangamudi M
PY  - 2026
JO  - Current pharmaceutical design
DO  - 10.2174/0113816128517337261019151723
UR  - https://doi.org/10.2174/0113816128517337261019151723
ER  - 

APA

N, A., BK, S., S, S., & M, V. (2026). 2D-QSAR and Molecular Docking Studies of 5-Nitrofuranyl Derivatives as Potential Galactofuranosyltransferase 2 Inhibitors for Antitubercular Therapy.. Current pharmaceutical design. https://doi.org/10.2174/0113816128517337261019151723

Source records